MedTrace Logo

Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia

NCT06584461 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether intravenous (IV) lidocaine reduces the incidence of perioperative respiratory complications (PRCs) in children with upper respiratory tract infections undergoing general anesthesia. The study will also evaluate the safety of IV lidocaine in this population. The main questions it aims to answer are:

1. Does IV lidocaine lower the incidence of perioperative respiratory complications (e.g., laryngospasm, cough, desaturation) compared to a placebo?
2. What are the side effects associated with the administration of IV lidocaine in these children? Researchers will compare IV lidocaine to a placebo to assess its effectiveness in reducing PRCs.

Conditions

  • Upper Respiratory Tract Infections
  • Perioperative Respiratory Complications

Interventions

DRUG

Lidocaine (drug)

IV lidocaine, administered once during the induction of anesthesia.

DRUG

Saline (NaCl 0,9 %) (placebo)

IV placebo (normal saline), administered once during the induction of anesthesia.

Sponsors & Collaborators

  • Tunis University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2023-12-31
Completion
2024-02-05

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584461 on ClinicalTrials.gov